ArticleScience translational medicine2024

Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy.

Xiuting Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.